# Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment

> **NCT02084004** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Xijing Hospital**

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Bifidobacterium viable pharmaceutics
- **DRUG:** Berberine Hydrochloride

## Key facts

- **NCT ID:** NCT02084004
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor have not enough money to support this trial
- **Last updated:** 2018-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084004, "Effects of Berberine Hydrochloride and Bifidobacterium in Diabetes Mellitus Prevention and Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02084004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*